| Drug General Information |
| Drug ID |
D0BO9V
|
| Former ID |
DCL001191
|
| Drug Name |
GSK2118436
|
| Synonyms |
Dabrafenib (BRAF inhibitor)
|
| Drug Type |
Small molecular drug
|
| Company |
GlaxoSmithKline
|
| Formula |
C23H20F3N5O2S2
|
| Canonical SMILES |
CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)<br />(=O)C4=C(C=CC=C4F)F)F
|
| InChI |
1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
|
| InChIKey |
BFSMGDJOXZAERB-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
85742096, 97089189, 135267955, 135626784, 137218156, 137218157, 138049917, 138603357, 152159629, 152258588, 160647424, 160667665, 162064811, 162111177, 162159504, 163835610, 164041952, 164157161, 174006404, 175265791, 175426342, 175427150, 177749723, 178103108, 184819928, 189269558, 198992931, 223390613, 223471424, 223701071, 223705114, 224333747, 227084590, 241382118, 242060326, 242586122, 243946599, 249583144, 250184662, 252088681, 252110194, 252215237, 252449036, 252451784, 252554230
|
| Target and Pathway |
| References |
